Histological assessment of oesophageal columnar mucosa

Best Practice and Research: Clinical Gastroenterology

Volumn 22, Issue 4, 2008, Pages 671-686

  Flejou, Jean François ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Barrett's oesophagus; dysplasia; intestinal metaplasia; intraepithelial neoplasia; oesophageal cancer

Indexed keywords

CYTOKERATIN; KI 67 ANTIGEN; PROTEIN P53; SULFOMUCIN; TUMOR MARKER;

ARGON PLASMA COAGULATION; ARTICLE; BARRETT ESOPHAGUS; CANCER INVASION; CANCER RISK; CANCER SCREENING; CARCINOMA IN SITU; CARDIA; CATHETER ABLATION; COLUMNAR EPITHELIUM; CRYOTHERAPY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DYSPLASIA; ELECTROCOAGULATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; INTESTINE MUCOSA; LOW LEVEL LASER THERAPY; LOWER ESOPHAGUS SPHINCTER; MUCOSA INFLAMMATION; NONHUMAN; PHOTODYNAMIC THERAPY; PRECANCER; REPRODUCIBILITY;

BARRETT ESOPHAGUS; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL NEOPLASMS; HUMANS; INTESTINAL MUCOSA; METAPLASIA; PRECANCEROUS CONDITIONS; PROGNOSIS;

EID: 47649132703     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2008.03.003     Document Type: Article

References (83)

1. Spechler S.J., and Goyal R.K. The columnar-lined esophagus, intestinal metaplasia and Norman Barrett. Gastroenterology 110 (1996) 614-621
2. Haggitt R.C. Adenocarcinoma in Barrett's esophagus: a new epidemic?. Hum Pathol 23 (1992) 475-476
3. Ronkainen J., Aro P., Storskrubb T., et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129 (2005) 1825-1831
4. Wolfsen H.C., and Wallace M.B. Reconsidering Barrett's esophagus: practical applications of biophotonics. Gastroenterology 134 (2008) 382-385
5. Conio M., Cameron A.J., Chak A., et al. Endoscopic treatment of high-grade dysplasia and early cancer in Barrett's oesophagus. Lancet Oncol 6 (2005) 311-321
6. Sharma P., Morales T.G., and Sampliner R.E. Short segment Barrett's esophagus - the need for standardization of the definition and endoscopic criteria. Am J Gastroenterol 93 (1998) 1033-1036
7. Spechler S.J., Zeroogian J.M., and Antonioli D.A. Prevalence of metaplasia at the gastroesophageal junction. Lancet 92 (1994) 414-418
8. Paull A., Trier J.S., Dalton M.D., et al. The histologic spectrum of Barrett's esophagus. N Engl J Med 295 (1976) 476-480
9. Sharma P., McQuaid K., Dent J., et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago workshop. Gastroenterology 127 (2004) 310-330
10. Sampliner E. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 97 (2002) 1888-1895
11. Faller G., Borchard F., Ell C., et al. Histopathological diagnosis of Barrett's mucosa and associated neoplasias: results of a consensus conference of the working group for gastroenterological pathology of the German Society for Pathology on 22 September 2001 in Erlangen. Virchows Arch 443 (2003) 597-601
12. Boyer J., Laugier R., Chemali M., et al. French Society of Digestive Endoscopy SFED guideline: monitoring of patients with Barrett's esophagus. Endoscopy 39 (2007) 840-842
13. Offerhaus G.J.A., Correa P., van Eeden S., et al. Report of an Amsterdam working group on Barrett esophagus. Virchows Arch 443 (2003) 601-607
14. Playford R.J. New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus. Gut 55 (2006) 442
15. Vakil N., van Zanten S.V., Kahrilas P., et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101 (2006) 1900-1920
16. Jones T.F., Sharma P., Daaboul B., et al. Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy. Dig Dis Sci 47 (2002) 2108-2111
17. Zwas F., Shields H.M., Doos W.G., et al. Scanning electron microscopy of Barrett's epithelium and its correlation with light microscopy and mucin stains. Gastroenterology 90 (1986) 1932-1941
18. Hassall E. Columnar-lined esophagus in children. Gastroenterol Clin N Am 26 (1997) 533-548
19. Chandrasoma P.T., Der R., Ma Y., et al. Histologic classification of patients based on mapping biopsies of the gastroesophageal junction. Am J Surg Pathol 27 (2003) 929-936
20. Jego M., Volant A., Faycal J., et al. Prevalence and topography of intestinal metaplasia in columnar lined esophagus. Gastroenterol Clin Biol 31 (2007) 601-606
21. Chandrasoma P.T., Der R., Dalton P., et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol 25 (2001) 1188-1193
22. Harrison R., Perry I., Haddadin W., et al. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol 102 (2007) 1154-1161
23. Cameron A.J., and Carpenter H.A. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 92 (1997) 586-591
24. Chatelain D., and Flejou J.F. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins. Virchows Arch 442 (2003) 18-24
25. Chandrasoma P. Four directed biopsies are better than eight random biopsies to find intestinal metaplasia in columnar lined esophagus. Am J Gastroenterol 102 (2007) 2352-2353
26. Genta R.M., Huberman R.M., and Graham D.Y. The gastric cardia in Helicobacter pylori infection. Hum Pathol 25 (1994) 915-919
27. Chen Y.Y., Wang H.H., Antonioli D.A., et al. Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction. Hum Pathol 30 (1999) 1488-1495
28. Younes M., Ertan A., Ergun G., et al. Goblet cell mimickers in esophageal biopsies are not associated with an increased risk for dysplasia. Arch Pathol Lab Med 131 (2007) 571-575
29. Matsukuma A., Mori M., and Enjoji M. Sulphomucin-secreting intestinal metaplasia in the human gastric mucosa. An association with intestinal-type gastric carcinoma. Cancer 66 (1990) 689-694
30. Rothery G.A., Patterson J.E., Stoddard C.J., and Day D.W. Histological and histochemical changes in the columnar lined (Barrett's) oesophagus. Gut 27 (1986) 1062-1068
31. Ormsby A.H., Goldblum J.R., Rice T.W., et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol 30 (1999) 288-294
32. Ormsby A.H., Vaezi M.F., Richter J.E., et al. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology 119 (2000) 683-690
33. Mohammed I.A., Streutker C.J., and Riddell R.H. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia. Mod Pathol 15 (2002) 611-616
34. Nurgalieva Z., Lowrey A., and El-Serag H.B. The use of cytokeratin stain to distinguish Barrett's esophagus from contiguous tissues: a systematic review. Dig Dis Sci 52 (2007) 1345-1354
35. DeMeester S.R., Wickramasinghe K.S., Lord R.V., et al. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am J Gastroenterol 97 (2002) 2514-2523
36. Guillem P., Billeret V., Buisine M.P., et al. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Int J Cancer 88 (2000) 856-861
37. Groisman G.M., Amar M., and Meir A. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia. Mod Pathol 17 (2004) 1282-1288
38. Spechler S.J. Intestinal metaplasia at the gastroesophageal junction. Gastroenterology 126 (2004) 567-575
39. Odze R.D. Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective. Am J Gastroenterol 100 (2005) 1853-1867
40. Chandrasoma P. Controversies of the cardiac mucosa and Barrett's esophagus. Histopathology 46 (2005) 361-373
41. Chandrasoma P., Makarewicz K., Wickramasinghe K., et al. A proposal for a new validated histological definition of the gastroesophageal junction. Hum Pathol 37 (2006) 40-47
42. Sharma P., Weston A.P., Morales T., et al. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut 46 (2000) 9-13
43. Srivastava A., Odze R.D., Lauwers G.Y., et al. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol 31 (2007) 1733-1741
44. Hornick J.L., and Odze R.D. Neoplastic precursor lesions in Barrett's esophagus. Gastroenterol Clin N Am 36 (2007) 775-796
45. Riddell R.H., Goldman H., Ransohoff D.F., et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14 (1983) 931-968
46. Schmidt H.G., Riddell R.H., Walther B., et al. Dysplasia in Barrett's esophagus. J Cancer Res Clin Oncol 110 (1985) 145-152
47. Werner M., Flejou J.F., Hainaut P., et al. Adenocarcinoma of the oesophagus. In: Hamilton S.R., and Aaltonen L.A. (Eds). Pathology and genetics of tumours of the digestive system (2000), IARC Press, Lyon 20-26
48. Geboes K., and Van Eyken P. The diagnosis of dysplasia and malignancy in Barrett's oesophagus. Histopathology 37 (2000) 99-107
49. Goldblum J.R., and Lauwers G.Y. Dysplasia arising in Barrett's esophagus: diagnostic pitfalls and natural history. Semin Diagn Pathol 19 (2002) 12-19
50. Montgomery E., Bronner M.P., Goldblum J.R., et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 32 (2001) 368-378
51. Lomo L.C., Blount P.L., Sanchez C.A., et al. Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort. Am J Surg Pathol 30 (2006) 423-435
52. Odze R.D. Diagnosis and grading of dysplasia in Barrett's oesophagus. J Clin Pathol 59 (2006) 1029-1038
53. Thurberg B.L., Duray P.H., and Odze R.D. Polypoid dysplasia in Barrett's esophagus: a clinicopathologic, immunohistochemical, and molecular study of five cases. Hum Pathol 30 (1999) 745-752
54. Weston A.P., Sharma P., Topalovski M., et al. Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol 95 (2000) 1888-1893
55. Reid B.J., Haggitt R.C., Rubin C.E., et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 19 (1988) 166-178
56. Alikhan M., Rex D., Khan A., et al. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. Gastrointest Endosc 50 (1999) 23-26
57. Ormsby A.H., Petras R.E., Henricks W.H., et al. Interobserver variation in Barrett's related high grade dysplasia and superficial carcinoma: can it be improved using uniform pathological criteria?. Gut 51 (2002) 671-676
58. Kerkhof M., van Dekken H., Steyerberg E.W., et al. Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 50 (2007) 920-927
59. Pech O., Vieth M., Schmitz D., et al. Conclusions from the histological diagnosis of low-grade intraepithelial neoplasia in Barrett's oesophagus. Scand J Gastroenterol 42 (2007) 682-688
60. Schlemper R.J., Riddell R.H., Kato Y., et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47 (2000) 251-255
61. Heitmiller R.F., Redmond M., and Hamilton S.R. Barrett's esophagus with high grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 224 (1996) 66-71
62. Falk G.W., Rice T.W., Goldblum J.R., and Richter J.E. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 49 (1999) 170-176
63. Levine D.S., Haggitt R.C., Blount P.L., et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 105 (1993) 40-50
64. Buttar N.S., Wang K.K., Sebo T.J., et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 120 (2001) 1630-1639
65. Conio M., Blanchi S., Lapertosa G., et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol 98 (2003) 1912-1913
66. Levine D.S., Haggitt R.C., and Irvine S. Natural history of high-grade dysplasia in Barrett's esophagus. Gastroenterology 110 (1996) A550 (abstract)
67. Dar M.S., Goldblum J.R., Rice T.W., and Falk G.W. Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?. Gut 52 (2003) 486-489
68. Montgomery E., Goldblum J.R., Greenson J.K., et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 32 (2001) 379-388
69. Skacel M., Petras R., Gramlich T., et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 95 (2000) 3383-3387
70. Srivastava A., Hornick J.L., Li X., et al. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 102 (2007) 483-493
71. Reid B.J., Blount P.L., and Rabinovitch P.S. Biomarkers in Barrett's esophagus. Gastrointest Endosc Clin N Am 13 (2003) 369-397
72. Fitzgerald R.C. Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut 55 (2006) 1810-1818
73. Rabinovitch P.S., Longton G., Blount P.L., et al. Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastroenterol 96 (2001) 3071-3083
74. Murray L., Sedo A., Scott M., et al. TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort. Gut 55 (2006) 1390-1397
75. Preston S.L., and Jankowski J.A. Drinking from the fountain of promise: biomarkers in the surveillance of Barrett's oesophagus - the glass is half full!. Gut 55 (2006) 1377-1379
76. Johnston J.H. Technology insight: ablative techniques for Barrett's esophagus - Current and emerging trends. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 323-330
77. Mino-Kenudson M., Brugge W.R., Puricelli W.P., et al. Management of superficial Barrett's epithelium-related neoplasms by endoscopic mucosal resection. Clinicopathologic analysis of 27 cases. Am J Surg Pathol 29 (2005) 680-686
78. Abraham S.C., Krasinskas A.M., Correa A.M., et al. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol 31 (2007) 1719-1725
79. Prasad G.A., Wang K.K., Lutzke L.S., et al. Frozen section analysis of esophageal endoscopic mucosal resection specimens in the real-time management of Barrett's esophagus. Clin Gastroenterol Hepatol 4 (2006) 173-178
80. Hull M.J., Mino-Kenudson M.M., Nishioka N.S., et al. Endoscopic mucosal resection. An improved diagnostic procedure for early gastroesophageal epithelial neoplasms. Am J Surg Pathol 30 (2006) 114-118
81. Fennerty M.B., Corless C.L., Sheppard B., et al. Pathological documentation of complete elimination of Barrett's metaplasia following endoscopic multipolar electrocoagulation therapy. Gut 49 (2001) 142-144
82. Wilkinson S.P., Biddlestone L., Gore S., et al. Regression of columnar-lined (Barrett's oesophagus with omeprazole 40 mg daily: results of 5 years continuous therapy. Aliment Pharmacol Ther 20 (2004) 1125-1131
83. Mino-Kenudson M., Ban S., Ohana M., et al. Buried dysplasia and early adenocarcinoma arising in Barrett esophagus after Porfimer-photodynamic therapy. Am J Surg Pathol 31 (2007) 403-409